Rates of hemorrhagic stroke, myocardial infarction, and cardiovascular death were 0.3%, 0.1%, and 0.2% in both groups. Death from any cause occurred in 0.4% of all patients.
CHANCE was funded by the Chinese Ministry of Science and Technology. Dr. Wang and his coauthors reported having no disclosures.